Impact of provider type and number of providers on surveillance testing among survivors of head and neck cancers.
Christopher M K L YaoShuangshuang FuSamantha H TamKimberley L KiongTheresa W GuoHui ZhaoSharon H GiordanoErich M SturgisCarol M LewisPublished in: Cancer (2021)
In this large SEER-Medicare data study, only half of HNC survivors received the recommended testing, and greater compliance was seen in those who followed up with both an oncologist and a PCP. More attention is needed to minimize variations in surveillance testing across sociodemographic groups.